Baxter

YTD

ALL

Trade Baxter 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BAX

Baxter International, Inc. engages in the provision of a portfolio of essential healthcare products including acute and chronic dialysis therapies, sterile intravenous (IV) solutions, infusion systems and devices, parenteral nutrition therapies, inhaled anesthetics, generic injectable pharmaceuticals, surgical hemostat and sealant products, surgical equipment, smart bed systems, patient monitoring and diagnostic technologies, and respiratory health devices. It operates through the following segments: Americas, Europe, Middle East and Africa (EMEA), Asia-Pacific (APAC), and Hillrom.

CEO

D. Brent Shafer

CEOD. Brent Shafer

Employees

38,000

Employees38,000

Headquarters

Deerfield, Illinois

HeadquartersDeerfield, Illinois

Founded

1931

Founded1931

Employees

38,000

Employees38,000

BAX Key Statistics

Market cap

12.16B

Market cap12.16B

Price-Earnings ratio

-89.23

Price-Earnings ratio-89.23

Dividend yield

3.40%

Dividend yield3.40%

Average volume

14.99M

Average volume14.99M

High today

$23.86

High today$23.86

Low today

$23.28

Low today$23.28

Open price

$23.53

Open price$23.53

Volume

10.24M

Volume10.24M

52 Week high

$40.49

52 Week high$40.49

52 Week low

$21.33

52 Week low$21.33

BAX News

Seeking Alpha 5d

Baxter downgraded to Hold at Stifel on weak Q2 report

Baxter (NYSE:BAX) has been downgraded to Hold from Buy at Stifel, with a revised target price of $25, down from $36 after a weak second quarter earnings report...

Analyst ratings

70%

of 20 ratings

Buy

20%

Hold

70%

Sell

10%

People also own

Based on the portfolios of people who own BAX. This list is generated using Robinhood data, and it’s not a recommendation.